Gilead Sciences, Inc.GILDNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank29
3Y CAGR-11.5%
5Y CAGR-3.0%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
-11.5%/yr
vs +3.9%/yr prior
5Y CAGR
-3.0%/yr
Recent deceleration
Acceleration
-15.4pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $3.92B | -37.3% |
| 2024 | $6.25B | -3.8% |
| 2023 | $6.50B | +14.9% |
| 2022 | $5.66B | -14.3% |
| 2021 | $6.60B | +44.4% |
| 2020 | $4.57B | -2.2% |
| 2019 | $4.67B | -3.7% |
| 2018 | $4.85B | +11.0% |
| 2017 | $4.37B | +2.6% |
| 2016 | $4.26B | - |